Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
Eligibility summary
This competition is open to collaborations only.
To lead a collaborative project your organisation must be:
- a UK registered business
- an academic institution
- an NHS organisation
The consortium must contain at least one UK registered micro, small or medium sized enterprise claiming grant funding on this application.